Marvel Biosciences Corp.

Marvel Biosciences is an agile, Calgary-based biotechnology company revolutionizing drug development by de-risking the (re)development of existing drugs to create novel therapeutics with enhanced efficacy and safety profiles. We capitalize on modifying known, off-patent drugs to deliver faster, safer, and more effective treatments. Our streamlined approach significantly reduces development costs, shortens timelines, and lowers risk compared to traditional biotech models. Our lead compound has shown remarkable promise in preclinical studies, demonstrating efficacy for a wide range of conditions, including depression, anxiety, Alzheimer's disease, and autism. We are also actively investigating its potential in addressing other genetic disorders, such as Rett syndrome and Fragile X syndrome, further expanding our therapeutic reach. We have completed cGMP synthesis, toxicology studies, and preparation for Phase 1 clinical trials and are well-positioned to bring our groundbreaking solutions to market.